These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37021137)

  • 21. Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?
    Ettema EM; Kuipers J; Assa S; Bakker SJ; Groen H; Westerhuis R; Gaillard CA; Gansevoort RT; Franssen CF
    PLoS One; 2015; 10(5):e0127116. PubMed ID: 25973954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in copeptin and bioactive vasopressin in runners with and without hyponatremia.
    Hew-Butler T; Hoffman MD; Stuempfle KJ; Rogers IR; Morgenthaler NG; Verbalis JG
    Clin J Sport Med; 2011 May; 21(3):211-7. PubMed ID: 21519298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease.
    Piani F; Reinicke T; Lytvyn Y; Melena I; Lovblom LE; Lai V; Tse J; Cham L; Orszag A; Perkins BA; Cherney DZI; Bjornstad P
    J Diabetes Complications; 2021 Mar; 35(3):107807. PubMed ID: 33288413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SGLT2 Inhibitors Correct Fluid Overload in Adult Kidney Transplant Recipients-A Prospective Observational Study.
    Schork A; Eberbach ML; Artunc F; Bohnert BN; Eisinger F; Heister DJ; Vosseler D; Nadalin S; Birkenfeld AL; Heyne N; Guthoff M
    Transpl Int; 2024; 37():12879. PubMed ID: 38915756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis.
    Refardt J; Winzeler B; Christ-Crain M
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):22-32. PubMed ID: 31004513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of sodium-glucose Co-transporter 2 inhibitors on clinical and biochemical markers of dehydration during the Holy Ramadan.
    Gameil MA; Marzouk RE; El-Sebaie AH; Eldeeb AAA
    Diabetes Metab Syndr; 2022 Sep; 16(9):102606. PubMed ID: 36063675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arginine Vasopressin and Copeptin in Perinatology.
    Evers KS; Wellmann S
    Front Pediatr; 2016; 4():75. PubMed ID: 27532032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort.
    Boertien WE; Meijer E; Li J; Bost JE; Struck J; Flessner MF; Gansevoort RT; Torres VE;
    Am J Kidney Dis; 2013 Mar; 61(3):420-9. PubMed ID: 23089511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressin but Not Oxytocin Responds to Birth Stress in Infants.
    Fill Malfertheiner S; Bataiosu-Zimmer E; Michel H; Fouzas S; Bernasconi L; Bührer C; Wellmann S
    Front Neurosci; 2021; 15():718056. PubMed ID: 34512251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of copeptin, the stable peptide of the vasopressin precursor, in the differential diagnosis of sodium imbalance in patients with acute diseases.
    Nigro N; Müller B; Morgenthaler N; Fluri F; Schütz P; Neidert S; Stolz D; Bingisser R; Tamm M; Christ-Crain M; Katan M
    Swiss Med Wkly; 2011; 141():w13270. PubMed ID: 21990032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semimechanistic modeling of copeptin and aldosterone kinetics and dynamics in response to rehydration treatment for diabetic ketoacidosis in children.
    Otto ME; Burckhardt MA; Szinnai G; Pfister M; Gotta V
    CPT Pharmacometrics Syst Pharmacol; 2023 Feb; 12(2):207-220. PubMed ID: 36510706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis.
    Hallow KM; Helmlinger G; Greasley PJ; McMurray JJV; Boulton DW
    Diabetes Obes Metab; 2018 Mar; 20(3):479-487. PubMed ID: 29024278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis.
    Sternlicht H; Bakris GL
    Curr Hypertens Rep; 2019 Feb; 21(2):12. PubMed ID: 30747296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of renal and cardiovascular protection mechanisms of SGLT2 inhibitors: model-based analysis of clinical data.
    Hallow KM; Greasley PJ; Helmlinger G; Chu L; Heerspink HJ; Boulton DW
    Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1295-F1306. PubMed ID: 30019930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers?
    Nobbenhuis R; Refardt J; Vogt D; Sailer CO; Winzeler B; Christ-Crain M
    Biomarkers; 2021 Nov; 26(7):647-655. PubMed ID: 34412521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copeptin, a surrogate marker of arginine
    Makwana R; Loy J; Adebibe M; Devalia K; Andrews PL; Sanger GJ
    Eur J Pharmacol; 2021 Feb; 892():173740. PubMed ID: 33220268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.
    Simmler LD; Hysek CM; Liechti ME
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2844-50. PubMed ID: 21715530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated plasma levels of copeptin linked to diabetic retinopathy in type 2 diabetes.
    Zhao Q; Wu XX; Zhou J; Wang X
    Mol Cell Endocrinol; 2017 Feb; 442():106-112. PubMed ID: 27940301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low Copeptin Levels in Patients With Intradialytic Hypotension.
    Korucu B; Helvaci O; Ozbas B; Yeter H; Yuce D; Elbeg S; Derici U
    Ther Apher Dial; 2019 Oct; 23(5):460-466. PubMed ID: 30549206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis.
    Fenske W; Sandner B; Christ-Crain M
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):219-33. PubMed ID: 27156760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.